View More
Expert faculty discuss the latest data on using SGLT2 inhibitors to reduce HF risk in patients with T2D
On-demand webinar on leveraging the cardioprotective effects of SGLT2 inhibitors to reduce heart failure risk in your patients with type 2 diabetes.
Expert faculty discusses why healthcare professionals should be vigilant in assessing for HF in patients with T2D and the evolving use of SGLT2 inhibitors in these patients.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.